Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300071927Phase 4Not yet recruiting
Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Department of Anesthesiology, Zhongshan Hospital of Fudan University. Primary endpoint: Consumption of hydromorphone 24 h after operation. Planned start Jul 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300071927.